SE7610940L - Forfarande for framstellning av benshydrylsulfinylderivat - Google Patents

Forfarande for framstellning av benshydrylsulfinylderivat

Info

Publication number
SE7610940L
SE7610940L SE7610940A SE7610940A SE7610940L SE 7610940 L SE7610940 L SE 7610940L SE 7610940 A SE7610940 A SE 7610940A SE 7610940 A SE7610940 A SE 7610940A SE 7610940 L SE7610940 L SE 7610940L
Authority
SE
Sweden
Prior art keywords
procedure
preparation
sulfinyl derivative
benzhydryl sulfinyl
benzhydryl
Prior art date
Application number
SE7610940A
Other languages
English (en)
Other versions
SE431088B (sv
Inventor
L Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of SE7610940L publication Critical patent/SE7610940L/sv
Publication of SE431088B publication Critical patent/SE431088B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
SE7610940A 1975-10-02 1976-10-01 Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat SE431088B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40419/75A GB1520812A (en) 1975-10-02 1975-10-02 Benzhydrylsulphinyl derivatives

Publications (2)

Publication Number Publication Date
SE7610940L true SE7610940L (sv) 1977-04-03
SE431088B SE431088B (sv) 1984-01-16

Family

ID=10414819

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7610940A SE431088B (sv) 1975-10-02 1976-10-01 Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat

Country Status (29)

Country Link
US (1) US4066686A (sv)
JP (1) JPS6045186B2 (sv)
AT (1) AT347426B (sv)
AU (1) AU511619B2 (sv)
BE (1) BE846880A (sv)
CH (1) CH614934A5 (sv)
CS (1) CS200195B2 (sv)
DE (1) DE2642511C2 (sv)
DK (1) DK151009C (sv)
ES (1) ES452063A1 (sv)
FI (1) FI63220C (sv)
FR (1) FR2326181A1 (sv)
GB (1) GB1520812A (sv)
GE (1) GEP19960242B (sv)
HU (1) HU175109B (sv)
IE (1) IE43553B1 (sv)
IL (1) IL50599A (sv)
LU (1) LU75909A1 (sv)
NL (1) NL187629C (sv)
NO (1) NO143219C (sv)
NZ (1) NZ182207A (sv)
OA (1) OA05444A (sv)
PH (1) PH12533A (sv)
PL (1) PL105506B1 (sv)
PT (1) PT65648B (sv)
SE (1) SE431088B (sv)
SU (1) SU651693A3 (sv)
YU (1) YU40464B (sv)
ZA (1) ZA765830B (sv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1106403A (en) * 1977-04-29 1981-08-04 Victor Lafon Process for preparing (3,4-dichlorophenyl-sulphinyl)- acetamidoxime and its addition salts
FR2528041A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
FR2528040A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Benzhydrylsulfinylethylamines, procede de preparation et utilisation en therapeutique
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
FR2561646B1 (fr) * 1984-03-23 1987-10-09 Lafon Labor Derives d'acide (a-(alkylaminomethyl)-benzyl)-thioacetique, procede de preparation et utilisation en therapeutique
FR2569186B1 (fr) * 1984-08-20 1986-09-05 Lafon Labor Derives de 1-(n-(a-amino-a-methylacetyl)-aminophenyl)-2-amino-propanone, procede de preparation et utilisation en therapeutique
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2606015B1 (fr) * 1986-08-13 1989-05-19 Lafon Labor Derives du benzhydrylthiomethane, leurs procedes de preparation et leurs applications en therapeutique
JPH02162176A (ja) * 1988-12-14 1990-06-21 Sanyo Electric Co Ltd ライトの取付装置
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5571825A (en) * 1995-03-31 1996-11-05 Warner-Lambert Company Method of selectively inhibiting prostaglandin G/H synthase-2
YU40999A (sh) * 1997-02-27 2002-06-19 American Cyanamid Company N-hidroksi-2-(alkil,aril ili heteroaril sulfanil,sulfinil ili sulfonil)-3-supstituisani alkil,aril ili heteroarilamidi, kao inhibitori za matrične metaloproteinaze
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6670358B2 (en) * 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
US6875893B2 (en) * 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
EP1437345A1 (en) * 2003-01-13 2004-07-14 Organisation de Synthese Mondiale Orsymonde Novel method for preparing methyl 2-diphenylmethylsulfinylacetate
CA2514900A1 (en) 2003-01-31 2004-09-10 Alembic Limited Process for the preparation of 2-[(diphenylmethyl) thio] acetamide
MXPA05008088A (es) * 2003-02-24 2005-09-21 Mallinckrodt Inc Proceso mejorado para preparar benzhidril tioacetamida.
ITMI20031298A1 (it) * 2003-06-26 2004-12-27 Erregierre Spa Processo di preparazione di modafinil forma polimorfa(i).
WO2005046854A2 (en) * 2003-09-12 2005-05-26 Sun Pharmaceutical Industries Limited A process for the preparation of diphenylmethylsulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
AU2007272501A1 (en) * 2006-07-12 2008-01-17 Elan Pharma International Limited Nanoparticulate formulations of modafinil
WO2008077127A2 (en) * 2006-12-19 2008-06-26 Lavin Thomas N Use of modafinil to treat restless leg syndrome
USD681056S1 (en) * 2012-09-09 2013-04-30 Apple Inc. Electronic device
WO2014138518A2 (en) 2013-03-08 2014-09-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
CN104610108B (zh) * 2015-01-27 2016-03-30 潍坊医学院 一种中枢神经系统药物阿屈非尼中间体化合物的合成方法
WO2019094856A1 (en) 2017-11-13 2019-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Atypical inhibitors of monoamine transporters; method of making; and use thereof
KR102126389B1 (ko) 2018-09-14 2020-06-25 셀라이온바이오메드 주식회사 벤즈히드릴티오 아세트아미드 화합물을 유효성분으로 포함하는 간 질환의 예방 또는 치료용 조성물
KR102277739B1 (ko) 2019-12-11 2021-07-15 셀라이온바이오메드 주식회사 벤즈히드릴 티오 아세트아미드 화합물을 유효성분으로 포함하는 섬유화 질환의 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2394597A (en) * 1942-07-09 1946-02-12 Eastman Kodak Co Preparation of organic dhsocyanates
NL6406688A (sv) * 1964-06-05 1965-12-06

Also Published As

Publication number Publication date
BE846880A (fr) 1977-04-01
FI762810A (sv) 1977-04-03
IL50599A0 (en) 1976-12-31
DE2642511C2 (de) 1986-07-31
ES452063A1 (es) 1977-10-01
PT65648A (pt) 1976-10-01
AT347426B (de) 1978-12-27
DK437576A (da) 1977-04-03
PL105506B1 (pl) 1979-10-31
CH614934A5 (sv) 1979-12-28
GEP19960242B (en) 1996-06-01
NL187629C (nl) 1991-12-02
IE43553B1 (en) 1981-03-25
AU1818876A (en) 1978-04-06
NZ182207A (en) 1978-03-06
IL50599A (en) 1980-09-16
NL7610929A (nl) 1977-04-05
DK151009C (da) 1988-02-29
ZA765830B (en) 1977-09-28
JPS5246058A (en) 1977-04-12
AU511619B2 (en) 1980-08-28
NO763372L (sv) 1977-04-05
FR2326181A1 (fr) 1977-04-29
PT65648B (fr) 1978-04-07
LU75909A1 (sv) 1977-05-11
CS200195B2 (cs) 1980-08-29
FI63220C (fi) 1983-05-10
DE2642511A1 (de) 1977-04-14
HU175109B (hu) 1980-05-28
ATA720876A (de) 1978-05-15
SE431088B (sv) 1984-01-16
IE43553L (en) 1977-04-02
DK151009B (da) 1987-10-12
NL187629B (nl) 1991-07-01
PH12533A (en) 1979-05-17
NO143219B (no) 1980-09-22
FR2326181B1 (sv) 1980-08-08
JPS6045186B2 (ja) 1985-10-08
US4066686A (en) 1978-01-03
NO143219C (no) 1981-01-07
SU651693A3 (ru) 1979-03-05
YU241476A (en) 1982-02-28
OA05444A (fr) 1981-03-31
FI63220B (fi) 1983-01-31
GB1520812A (en) 1978-08-09
YU40464B (en) 1986-02-28

Similar Documents

Publication Publication Date Title
SE7610940L (sv) Forfarande for framstellning av benshydrylsulfinylderivat
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7603791L (sv) Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE433610B (sv) Forfarande for framstellning av aromatiska uretaner
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
SE7611280L (sv) Forfarande for framstellning av 3-hydroxi-3-cefemestersulfoxider
SE423902B (sv) Forfarande for framstellning av purinderivat
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE409455B (sv) Analogiforfarande for framstellning av nitroimidazolyl-kinazolinderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat
SE7614091L (sv) Forfarande for framstellning av tiadiazolylderivat av 7-acylamido-3-cefem-4-karbonsyra
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7605427L (sv) Forfarande for framstellning av klorcyan
SE7603682L (sv) Forfarande for framstellning av en eteriskt substituerad monosackarid
SE7601247L (sv) Forfarande for framstellning av tienopyridinderivat
SE7604861L (sv) Forfarande for framstellning av bensobicyklononenderivat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7610940-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7610940-4

Format of ref document f/p: F